Drug Profile
Fc-IFN beta
Alternative Names: Fc-Interferon beta; Long-acting interferon - Merck SeronoLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Merck Serono
- Class Interferons; Recombinant fusion proteins
- Mechanism of Action Immunomodulators; Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Multiple sclerosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Multiple-sclerosis in Europe (Parenteral)
- 15 May 2012 Phase-I clinical trials in Multiple sclerosis in Europe (Parenteral)